LUMOS DIAGNOSTICS HOLDINGS LIMITED (LDX)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
LDX - LUMOS DIAGNOSTICS HOLDINGS LIMITED
FNArena Sector :
Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.74
Index:
FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.74
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.061
27 Mar |
-0.001 OPEN $0.06 |
-1.61% HIGH $0.06 |
2,779,210 LOW $0.06 |
OTHER COMPANIES IN THE SAME SECTOR | |||
4DX . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VHT . VTI . |
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | -5.7 |
DPS All | xxx | xxx | xxx | xxx | 0.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | 15.7 M |
Book Value Per Share | xxx | xxx | xxx | xxx | 4.6 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | -14.3 M |
Net Profit Margin | xxx | xxx | xxx | xxx | -85.15 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | -66.22 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | -43.75 % |
Return on Assets | xxx | xxx | xxx | xxx | -29.02 % |
Return on Equity | xxx | xxx | xxx | xxx | -66.22 % |
Return on Total Capital | xxx | xxx | xxx | xxx | -46.23 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | -14.5 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | 3 M |
Long Term Debt | xxx | xxx | xxx | xxx | 12 M |
Total Debt | xxx | xxx | xxx | xxx | 15 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | 5 M |
Price To Book Value | xxx | xxx | xxx | xxx | 0.24 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | 0.2 M |
Capex % of Sales | xxx | xxx | xxx | xxx | 1.47 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | 22 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | 9 M |
Research & Development | xxx | xxx | xxx | xxx | 1 M |
Investments - Total | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
LDX STOCK CHART
FNArena News on LDX
1 |
Dr Boreham’s Crucible: Lumos DiagnosticsJun 19 2023 - Small Caps |
2 |
Australian Broker Call *Extra* Edition – Mar 21, 2023Mar 21 2023 - Daily Market Reports |
3 |
Australian Broker Call *Extra* Edition – Sep 06, 2022Sep 06 2022 - Daily Market Reports |
4 |
Australian Broker Call *Extra* Edition – Aug 10, 2022Aug 10 2022 - Daily Market Reports |
5 |
Australian Broker Call *Extra* Edition – Jul 18, 2022Jul 18 2022 - Daily Market Reports |
Latest Medical Equipment & Devices News
1 |
Uptrend Resumed For ResMedMar 19 2024 - Technicals |
2 |
Dr Boreham’s Crucible: CochlearFeb 28 2024 - Australia |
3 |
Rudi Interviewed: Ongoing Potential In Technology & GrowthFeb 19 2024 - Rudi's View |
4 |
Dr Boreham’s Crucible: ArtryaFeb 15 2024 - Small Caps |
5 |
ResMed Recovery Turns Into Hollywood ScriptJan 31 2024 - Australia |
6 |
ResMed Makes A ComebackJan 29 2024 - Australia |
7 |
ResMed: The Recovery Has BegunJan 23 2024 - Technicals |
8 |
Dr Boreham’s Crucible: Pro MedicusOct 23 2023 - Australia |
9 |
Dr Boreham’s Crucible: CyclopharmOct 09 2023 - Small Caps |
10 |
Dr Boreham’s Crucible: PainchekSep 11 2023 - Small Caps |